Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Hemophagocytic Lymphohistiocytosis Due to Primary HHV-8 Infection in a Liver Transplant Recipient.

Cohen GM, Langer AL, Sima H, Chang C, Troy K, Taimur S.

Transplant Direct. 2018 Nov 27;4(12):e411. doi: 10.1097/TXD.0000000000000850. eCollection 2018 Dec.

2.

Distribution of Hepatitis C Virus Genotypes in Patients with Major β-Thalassemia in Mashhad, Northeast Iran.

Ahmadi-Ghezeldasht S, Badiei Z, Sima HR, Hedayati-Moghaddam MR, Habibi M, Khamooshi M, Azimi A.

Middle East J Dig Dis. 2018 Jan;10(1):35-39. doi: 10.15171/mejdd.2017.88. Epub 2018 Jan 7.

3.

Comparison of Interferon-Gamma (IFNG) +874 T/A Single Nucleotide Polymorphism in Hepatitis C Virus Infected Patients and Non-Infected Controls in Mashhad, Iran.

Rostami S, Pasdar A, Gerayli S, Hatami H, Sepahi S, Nategh F, Meshkat M, Hoseini SM, Ahadi M, Sima HR, Vosughinia H, Sarvghad MR, Esmaeelzade A, Nomani H, Mosanan Mozafari H, Rezai Talab F, Shakeri MT, Meshkat Z.

Iran J Pathol. 2017 Summer;12(3):248-256. Epub 2017 May 31. No abstract available.

4.

EGFR Expression in Patients with Esophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran.

Anvari K, Sima HR, Seilanian Toussi M, Anvari A, Shahidsales S, Memar B, Aledavoud SA, Forghani MN, Abdollahi A, Ghaffarzadegan K.

Arch Iran Med. 2017 Apr;20(4):240-245. doi: 0172004/AIM.0010.

5.

Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.

Lim KB, Sima HR, Fiel MI, Khaitova V, Doucette JT, Chernyiak M, Ahmad J, Bach N, Chang C, Grewal P, Kim-Schluger L, Liu L, Odin J, Perumalswami P, Florman SS, Schiano TD.

World J Gastroenterol. 2015 May 28;21(20):6236-45. doi: 10.3748/wjg.v21.i20.6236.

6.

A morphometric study of the hepatic arterioles in end-stage primary sclerosing cholangitis.

Fiel MI, Sima HR, Azarian A, Schiano TD.

Virchows Arch. 2015 Feb;466(2):143-9. doi: 10.1007/s00428-014-1680-9. Epub 2014 Nov 22.

PMID:
25416080
7.

Serum chemokine ligand 5 (CCL5/RANTES) level might be utilized as a predictive marker of tumor behavior and disease prognosis in patients with gastric adenocarcinoma.

Sima AR, Sima HR, Rafatpanah H, Hosseinnezhad H, Ghaffarzadehgan K, Valizadeh N, Mehrabi Bahar M, Hakimi HR, Masoom A, Noorbakhsh A, Razavi Satvati N, Raziee HR.

J Gastrointest Cancer. 2014 Dec;45(4):476-80. doi: 10.1007/s12029-014-9652-5.

PMID:
25301002
8.

INF- α and ototoxicity.

Sharifian MR, Kamandi S, Sima HR, Zaringhalam MA, Bakhshaee M.

Biomed Res Int. 2013;2013:295327. doi: 10.1155/2013/295327. Epub 2013 Jul 25.

9.

The prevalence of hepatitis C virus in mashhad, iran: a population-based study.

Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, Rostami S, Meshkat Z.

Hepat Mon. 2013 Mar 12;13(3):e7723. doi: 10.5812/hepatmon.7723. Print 2013 Mar.

10.

Increased thickness of abdominal subcutaneous adipose tissue occurs more frequently in steatohepatitis than in simple steatosis.

Fiel MI, Sima HR, Desman G, Azarian A, Lento P, Schiano TD.

Arch Pathol Lab Med. 2013 May;137(5):642-6. doi: 10.5858/arpa.2012-0050-OA.

PMID:
23627455
11.

The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran.

Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR.

Hepat Mon. 2011 May;11(5):346-50.

12.

Clinicopathological significance of macrophage migration inhibitory factor and its relation with p53 in gastric cancer.

Nabizadeh Marvast M, Sima HR, Ghaffarzadehgan K, Taghizadeh Kermani A, Norouzi N.

J Gastrointest Cancer. 2011 Mar;42(1):5-10. doi: 10.1007/s12029-010-9215-3.

PMID:
20922580
13.

Influence of processing on the allergenic properties of pistachio nut assessed in vitro.

Noorbakhsh R, Mortazavi SA, Sankian M, Shahidi F, Maleki SJ, Nasiraii LR, Falak R, Sima HR, Varasteh A.

J Agric Food Chem. 2010 Sep 22;58(18):10231-5. doi: 10.1021/jf101364g.

PMID:
20735130
14.

Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.

Boroumand-Noughabi S, Sima HR, Ghaffarzadehgan K, Jafarzadeh M, Raziee HR, Hosseinnezhad H, Moaven O, Rajabi-Mashhadi MT, Azarian AA, Mashhadinejad M, Tavakkol-Afshari J.

BMC Cancer. 2010 Jun 10;10:275. doi: 10.1186/1471-2407-10-275.

15.

Interactions between Glutathione-S-Transferase M1, T1 and P1 polymorphisms and smoking, and increased susceptibility to esophageal squamous cell carcinoma.

Moaven O, Raziee HR, Sima HR, Ganji A, Malekzadeh R, A'rabi A, Abdollahi A, Memar B, Sotoudeh M, Naseh H, Nekoui N, Razavipour A, Gholamin M, Dadkhah E, Farshchian M, Abbaszadegan MR.

Cancer Epidemiol. 2010 Jun;34(3):285-90. doi: 10.1016/j.canep.2010.03.009. Epub 2010 Apr 20.

PMID:
20409775
16.

Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.

Ghaffarzadehgan K, Jafarzadeh M, Raziee HR, Sima HR, Esmaili-Shandiz E, Hosseinnezhad H, Taghizadeh-Kermani A, Moaven O, Bahrani M.

World J Gastroenterol. 2008 Nov 7;14(41):6376-81.

17.

p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer.

Abbaszadegan MR, Moaven O, Sima HR, Ghafarzadegan K, A'rabi A, Forghani MN, Raziee HR, Mashhadinejad A, Jafarzadeh M, Esmaili-Shandiz E, Dadkhah E.

World J Gastroenterol. 2008 Apr 7;14(13):2055-60.

18.

Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran.

Abbaszadegan MR, Tavasoli A, Velayati A, Sima HR, Vosooghinia H, Farzadnia M, Asadzedeh H, Gholamin M, Dadkhah E, Aarabi A.

World J Gastroenterol. 2007 Mar 14;13(10):1528-33.

Supplemental Content

Loading ...
Support Center